Mr Palmer said he was confident of now finding a partner to take Cetilistat through the next stage of costly Phase III trials.
"We have had a lot of interest. There are a number of people asking for this data and to see the compound," he said.
I do not think Mr Palmer was sending the above messages re. confidence / interest in Renza and therefore think he is certain of landing a deal. The only question is when and how much. Looks to me there could be several bidders for Cetilistat consequently increasing the value for Cetilistat and AZM sp.